Drug
Furosemide/Digoxin Topical Gel CLS003 clinical trials
Also written CLS003.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Furosemide/Digoxin Topical Gel CLS003 is read from its arms, and is right about nine times in ten.
Testing it · 3
- ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent PatientsTerminatedPhase 2Maruho Co., Ltd.NCT03334240Written as CLS003
- A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.CompletedPhase 2Maruho Co., Ltd.NCT02333643Written as CLS003
- First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous WartsCompletedPhase 1/2Maruho Co., Ltd.NCT02106260Written as CLS003